SCHEMBL12601196

SCHEMBL12601196

O=Cc1ccc(-c2nc(-c3ccc(Br)cc3)c(-c3ccccc3)[nH]2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.78
MAPK12 P53778 10/20 0.78
MAPK11 Q15759 10/20 0.78
MAPK14 Q16539 10/20 0.78
GCGR P47871 6/20 0.78
TP53 P04637 3/20 0.69
MAPT P10636 3/20 0.69
RAF1 P04049 4/20 0.56
MAPK9 P45984 1/20 0.55
NOX1 Q9Y5S8 1/20 0.53
KMT2A Q03164 3/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
GLA P06280 2/20 0.53
GAA P10253 2/20 0.53
HPGD P15428 2/20 0.53
BRAF P15056 1/20 0.51
ALOX5 P09917 1/20 0.51
MEN1 O00255 2/20 0.51
THRB P10828 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28883313 0.93 MAPK13 (0.65) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL11176392 0.89 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL28158811 0.82 MAPK13 (0.86) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL12561692 0.82 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL14045570 0.82 MAPK13 (0.85) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469543 0.82 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2650068 0.82 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL12561695 0.81 KDM4E (0.80) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL28789580 0.81 MAPK13 (0.62) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL5074753 0.81 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152337-A1 2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS LORUS THERAPEUTICS INC. (CA) 2011-06-23 US disclosed
US-7884120-B2 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides LORUS THERAPEUTICS INC. (CA) 2011-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152337-A1 2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS IDO2, ERG28, IL4 MAPK13 3668/4885MAPK12 3161/4885MAPK11 3626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.